[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Sat, Jun 13th, 2026

PR Newswire Releases

Sat, Jun 13th, 2026
Contributor Content

This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here

Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

NEW YORK , June 13, 2026 /PRNewswire/ -- 

TBRG : 26.12 (+0.19%)
Verra Mobility Corporation (VRRM) Securities Fraud Class Action Lawsuit Filed; August 4, 2026, Lead Plaintiff Deadline

Did you buy VRRM common stock between February 24, 2026 and May 26, 2026?

VRRM : 4.67 (+3.78%)
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

INDIANAPOLIS , June 13, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the Phase 1 AJX-101 study showing that its investigational type II JAK2 inhibitor (AJ1-11095)...

LLY : 1,133.00 (-2.41%)
PicS N.V. (PICS) Class Action Lawsuit: Investors Face August 4, 2026, Deadline

Did you buy PICS Class A common stock on or around January 30, 202 6?

PICS : 10.82 (unch)
Rosen Law Firm Encourages Blaize Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - BZAI

NEW YORK , June 13, 2026 /PRNewswire/ --

BZAI : 1.4700 (-4.55%)
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

STOCKHOLM , June 13, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced results from the investigational Phase 3 MonumenTAL-3 study...

JNJ : 240.87 (+1.07%)
Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J. , June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a global provider of IT solutions and services, today opened a new delivery center at Gujarat...

SES AI Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against SES AI Corporation - SES

NEW ORLEANS , June 12, 2026 /PRNewswire/ -- ClaimsFiler , a FREE shareholder information service, reminds investors that they have until June 26, 2026 to file lead plaintiff applications...

SES : 1.0700 (unch)
PicS Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PicS N.V. - PICS

NEW ORLEANS , June 12, 2026  /PRNewswire/ --  ClaimsFiler , a FREE shareholder information service, reminds investors that they have until August 4, 2026 to file lead plaintiff...

PICS : 10.82 (unch)
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

NEW ORLEANS , June 12, 2026 /PRNewswire/ -- ClaimsFiler , a FREE shareholder information service, reminds investors that they have until August 10, 2026 to file lead plaintiff applications...

ADMA : 8.21 (-1.32%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.